» Articles » PMID: 38444796

Antimalarial Prophylaxis Failure: Malaria in a Returning Traveler Despite Mefloquine Prophylaxis

Overview
Journal Trop Parasitol
Specialty Parasitology
Date 2024 Mar 6
PMID 38444796
Authors
Affiliations
Soon will be listed here.
Abstract

This case report presents a perplexing case of breakthrough infection despite prophylaxis with appropriate antimalarial prophylactic regimen of mefloquine in a compliant patient. A 78-year-old missionary who travels each year to the African subcontinent for multiple weeks to months, over 25 years, adheres to stringent antimalarial prophylaxis with Mefloquine as prescribed, starting prior to the trip and continuing after the return to the U.S.A. She gave no prior history of malaria during her 25 years of travel to Africa and back. Since she had no prior history of malaria and due to her excellent compliance with antimalarial regiment, despite her presentation which were suggestive of malaria, neither the patient nor her providers recognized the onset of malaria in this case. Infectious diseases physicians approached this case with an open mind, investigated appropriately, requested appropriate tests, found the presence of malarial parasite, identified as species thereafter. She was started on antimalarial treatment in a timely fashion and showed an excellent response. This intriguing recovery of malarial parasite and response to treatment despite the patient being on antimalarial prophylaxis raised the possibility of mefloquine failure as an antimalarial prophylactic agent against species.

References
1.
Schwartz E, Parise M, Kozarsky P, Cetron M . Delayed onset of malaria--implications for chemoprophylaxis in travelers. N Engl J Med. 2003; 349(16):1510-6. DOI: 10.1056/NEJMoa021592. View

2.
Mueller I, Zimmerman P, Reeder J . Plasmodium malariae and Plasmodium ovale--the "bashful" malaria parasites. Trends Parasitol. 2007; 23(6):278-83. PMC: 3728836. DOI: 10.1016/j.pt.2007.04.009. View

3.
Ahmad S, Rahi M, Ranjan V, Sharma A . Mefloquine as a prophylaxis for malaria needs to be revisited. Int J Parasitol Drugs Drug Resist. 2021; 17:23-26. PMC: 8342532. DOI: 10.1016/j.ijpddr.2021.06.003. View

4.
Li J, Lundsmith E . Empiric Treatment for Suspected Malaria in the United States: A Case Report. Cureus. 2020; 12(4):e7885. PMC: 7255543. DOI: 10.7759/cureus.7885. View

5.
Rodrigo C, Rajapakse S, Deepika Fernando S . Compliance with Primary Malaria Chemoprophylaxis: Is Weekly Prophylaxis Better Than Daily Prophylaxis?. Patient Prefer Adherence. 2020; 14:2215-2223. PMC: 7665499. DOI: 10.2147/PPA.S255561. View